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INTRODUCTION
Hemophagocytic lymphohistiocytosis (HLH) is a rare 
syndrome of overwhelming immune activation causing 
multiorgan dysfunction that may be genetic and/or acquired 
(Figure 1). Patients with familial HLH often present by one 
year of age, though most are asymptomatic in the first 
month of life. We present the case of a neonate with 
diarrhea and malnutrition who developed signs and 
symptoms consistent with a clinical diagnosis of HLH. 
CASE
• HPI: Neonate born at 35 5/7 weeks, transferred to a 
Level IV NICU at 39 4/7 weeks for failure to thrive
• Feeding adequately, but had persistent diarrhea on 
multiple formulas, only gained small amounts of 
weight via total parental nutrition (Figure 2)
• Family/social history: first child of consanguineous 
parents of South Asian descent, otherwise 
noncontributory
• Physical exam: Appeared malnourished but non-
dysmorphic 
• Gastrointestinal workup: Inconsistent with milk soy 
protein intolerance and malabsorption syndromes. 
• Considered very-early-onset inflammatory bowel 
disease and congenital diarrheas/enteropathies
• Endoscopy with intestinal biopsy concerning for an 
underlying primary immunodeficiency 
• Genetic and immunology workup: Mild increase in T 
cells and low IgM
• Chromosomal microarray with 7.8% genome wide 
regions of homozygosity, supporting increased risk of 
autosomal recessive conditions
• Lymphocyte proliferation to mitogens and expression 
of FOXP3, XIAP, and SAP by flow cytometry all 
unremarkable
• Perforin/granzyme B expression was increased
• Clinical course: At age 44 weeks, he acutely became 
lethargic, with fevers up to 40°C and metabolic acidosis
• Further developed anemia, thrombocytopenia, 
lymphocytosis, transaminitis, and 
hepatosplenomegaly (Figure 3) 
• Hypofibrinogenemia, hyperferritinemia (>10,000), and 
elevated Soluble IL-2R led to HLH diagnosis (Table 1) 
• Treatment: Dexamethasone and etoposide per HLH 94 
protocol; emapalumab also administered
• Outcome: Developed fulminant liver failure and 
uncontrollable DIC despite treatment
• Life-sustaining treatments were withdrawn and he 
died at 46 3/7 weeks
DISCUSSION
• Though colitis is not classically a feature of most primary HLH syndromes, it 
has been described in one subset of familial HLH (familial HLH 5 syndrome) 
along with hypogammaglobulinemia. However, sequencing of the associated 
gene (STXBP2) was normal in our patient.
• Similarly, among EBV-driven HLH, X-linked lymphoproliferative disease and 
XIAP deficiency are associated with hypogammaglobulinemia and colitis 
respectively, however expression of these was normal in our patient with no 
evidence of EBV viremia. 
• Whole exome sequencing received after patient’s death was ultimately 
nondiagnostic. Variants of unknown significance included: 
• BCOR (c.4927T>C; p.Ser1643Pro – maternally inherited)
• GUCY2C (c.1092C>A; p.Asp364Glu – paternally inherited) 
• STEAP3 (c.703G>A; p.Val235Ile – maternally inherited) 
• None of the associated conditions and molecular characteristics of these 
specific variants have adequate established phenotypic overlap with our 
patient’s presentation to make them clinically actionable.
• Neonatal patients are more likely to have genetic causes for HLH; parental 
consanguinity increase the risk for expression of these autosomal recessive 
conditions.
• Around 40% of neonatal presentations do not have an established genetic 
diagnosis after whole exome sequencing.
• Additional genes associated with early HLH presentation are likely yet to 
be discovered.
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Timely recognition of HLH maximizes the potential for effective treatment like 
hematopoietic stem cell transplantation. Recognition of colitis as a presenting 
symptom may facilitate this challenging diagnosis. Rapid and inclusive genetic 
evaluation, including WES, may help identify the underlying etiology and guide 
treatment for neonatal HLH.
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CONCLUSION
Figure 3: Patient after acute 
development of hepato-
splenomegaly and ascites
Figure 2: Patient’s growth chart with nutritional support (Weight-for-age 
percentiles, premature boys)
Figure 1: Genetic 
abnormalities 
associated with HLH 
result in impaired 
cytotoxic function of 
NK and T cells, 
leading to sustained 
activation of 
macrophages.
Woods et. al. Advances in 
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Table 1: Diagnostic criteria 
for HLH (need 5 of 8)
